Haseki Training and Research Hospital, Department of Neurology, Istanbul, Turkey.
J Clin Neurosci. 2013 Oct;20(10):1469-70. doi: 10.1016/j.jocn.2012.11.017. Epub 2013 Jul 16.
We aimed to investigate the relationship between olfactory function and olfactory bulbus (OB) volume, disease duration and Unified Parkinson's disease rating scale (UPDRS) scores in early stage idiopathic Parkinson's disease patients. The University of Pennsylvania Smell Identification Test (UPSIT) was used for the evaluation of olfactory function. UPSIT scores for patients with Parkinson's disease were significantly lower than controls. There was no significant difference between stage 1 and stage 2 patients. OB volumes were higher in stage 1 and 2 patients than controls, but there was no statistical difference between the three groups. No significant correlation was found between UPSIT and UPDRS total scores, nor between UPSIT scores and disease duration in stage 1 and 2 patients. According to our results, we propose UPSIT be used as a screening test to diagnose presymptomatic patients, but not OB volumes.
我们旨在研究早期特发性帕金森病患者的嗅觉功能与嗅球(OB)体积、疾病持续时间和统一帕金森病评定量表(UPDRS)评分之间的关系。宾夕法尼亚大学嗅觉识别测试(UPSIT)用于评估嗅觉功能。帕金森病患者的 UPSIT 评分明显低于对照组。1 期和 2 期患者之间无显著差异。1 期和 2 期患者的 OB 体积高于对照组,但三组之间无统计学差异。在 1 期和 2 期患者中,UPSIT 与 UPDRS 总分之间以及 UPSIT 评分与疾病持续时间之间均无显著相关性。根据我们的结果,我们建议使用 UPSIT 作为诊断无症状患者的筛查测试,但 OB 体积不适用。